These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8872524

  • 1. Mutagenic activation of N-nitrosobis(2-oxopropyl)amine by pancreatic juice and assessment of its ductal tumorigenicity following intraductal administration in dogs.
    Kamano T, Mori Y, Suda K, Takahashi M, Uchida T, Takada T, Tsutsumi M, Konishi Y.
    Int J Pancreatol; 1996 Aug; 20(1):51-7. PubMed ID: 8872524
    [Abstract] [Full Text] [Related]

  • 2. Species specificity in the metabolism of N-nitrosobis(2-oxopropyl)amine and N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine to mutagens by isolated rat and hamster hepatocytes.
    Mangino MM, Hollenberg PF, Scarpelli DG.
    Cancer Res; 1987 Sep 15; 47(18):4776-81. PubMed ID: 3113724
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of three radiolabeled pancreatic carcinogenic nitrosamines in hamsters and rats.
    Gingell R, Brunk G, Nagel D, Pour P.
    Cancer Res; 1979 Nov 15; 39(11):4579-83. PubMed ID: 227588
    [Abstract] [Full Text] [Related]

  • 4. Activation of N-nitrosobis(2-oxopropyl)amine and N-nitroso(2-hydroxypropyl)-(2-oxopropyl)amine to mutagens for V79 cells by isolated hamster and rat pancreatic acinar cells.
    Mangino MM, Scarpelli DG, Hollenberg PF.
    Cancer Res; 1985 Nov 15; 45(11 Pt 1):5219-24. PubMed ID: 4053002
    [Abstract] [Full Text] [Related]

  • 5. High mutagenic activity of N-nitrosobis(2-oxopropyl)amine and N-nitrosobis(2-hydroxypropyl)amine in the host-mediated assay in hamsters: evidence for premutagenic methyl and hydroxylpropyl adducts.
    Guttenplan JB, Kokkinakis D.
    Carcinogenesis; 1993 Aug 15; 14(8):1621-5. PubMed ID: 8353845
    [Abstract] [Full Text] [Related]

  • 6. Carcinogenic effect of N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, a postulated proximate pancreatic carcinogen in Syrian hamsters.
    Pour P, Wallcave L, Gingell R, Nagel D, Lawson T, Salmasi S, Tines S.
    Cancer Res; 1979 Oct 15; 39(10):3828-33. PubMed ID: 225009
    [Abstract] [Full Text] [Related]

  • 7. Mutagenicity of several pancreatic carcinogenic derivatives of N-nitrosodipropylamine in the Ames assay.
    Wislocki P, Gingell R.
    Mutat Res; 1980 Mar 15; 77(3):215-9. PubMed ID: 6991919
    [Abstract] [Full Text] [Related]

  • 8. Metabolism of the pancreatic carcinogen N-nitroso-bis(2-oxopropyl)amine after oral and intraperitoneal administration to Syrian golden hamsters.
    Gingell R, Pour P.
    J Natl Cancer Inst; 1978 Apr 15; 60(4):911-3. PubMed ID: 633398
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metabolism of pancreatic carcinogens N-nitroso-2,6-dimethylmorpholine and N-nitrosobis(2-oxopropyl)amine by microsomes and cytosol of hamster pancreas and liver.
    Kokkinakis DM, Scarpelli DG, Rao MS, Hollenberg PF.
    Cancer Res; 1983 Dec 15; 43(12 Pt 1):5761-7. PubMed ID: 6640529
    [Abstract] [Full Text] [Related]

  • 11. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
    Mori Y, Yamazaki H, Toyoshi K, Makino T, Obara T, Yokose Y, Konishi Y.
    Carcinogenesis; 1985 Mar 15; 6(3):415-20. PubMed ID: 3884171
    [Abstract] [Full Text] [Related]

  • 12. Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man.
    Mori Y, Yamazaki H, Toyoshi K, Maruyama H, Konishi Y.
    Mutat Res; 1986 May 15; 160(3):159-69. PubMed ID: 3960034
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparative study of the mutagenic activation of N-nitrosopropylamines by various animal species and man: evidence for a cytochrome P-450 dependent reaction.
    Yamazaki H, Mori Y, Toyoshi K, Nagai H, Koda A, Konishi Y.
    Jpn J Cancer Res; 1986 Feb 15; 77(2):107-17. PubMed ID: 3082822
    [Abstract] [Full Text] [Related]

  • 16. Mutagenic activities of oxidized derivatives of N-nitrosodipropylamine in the liver cell-mediated and Salmonella typhimurium assays.
    Langenbach R, Gingell R, Kuszynski C, Walker B, Nagel D, Pour P.
    Cancer Res; 1980 Oct 15; 40(10):3463-7. PubMed ID: 7002287
    [Abstract] [Full Text] [Related]

  • 17. Mutagenicity in V79 cells of N-nitrosobis(2-hydroxypropyl)amine and N-nitrosobis(2-oxopropyl)amine activated by tissues from hamsters fed low and high fat diets.
    Lawson T.
    Carcinogenesis; 1992 Feb 15; 13(2):223-6. PubMed ID: 1740011
    [Abstract] [Full Text] [Related]

  • 18. Mutation of V79 cells by N-dialkylnitrosamines after activation by hamster pancreas duct cells.
    Lawson T, Kolar C.
    Mutat Res; 1992 Oct 15; 272(2):139-44. PubMed ID: 1383746
    [Abstract] [Full Text] [Related]

  • 19. Metabolism and activation of the pancreatic carcinogen N-nitrosobis(2-oxopropyl)amine by isolated hepatocytes and pancreatic cells of the Syrian hamster.
    Mangino MM, Scarpelli DG, Kokkinakis DM.
    Carcinogenesis; 1990 Apr 15; 11(4):625-31. PubMed ID: 2108819
    [Abstract] [Full Text] [Related]

  • 20. Carcinogenicity of N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, N-nitrosobis(2-hydroxypropyl)amine and cis-N-nitroso-2,6-dimethylmorpholine administered continuously in the Syrian hamster, and the effect of dietary protein on N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine carcinogenesis.
    Kokkinakis DM, Scarpelli DG.
    Carcinogenesis; 1989 Apr 15; 10(4):699-704. PubMed ID: 2649266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.